Wafergen Bio-Sys Cmn (WGBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,315 | -10,693 | -16,266 | -8,177 | -13,145 |
| Depreciation Amortization | 1,252 | 1,156 | 2,814 | 2,089 | 948 |
| Income taxes - deferred | 128 | N/A | N/A | N/A | N/A |
| Accounts receivable | -720 | -1,114 | -61 | -279 | 749 |
| Accounts payable and accrued liabilities | 535 | 513 | 507 | -298 | -425 |
| Other Working Capital | -1,852 | 899 | 808 | -270 | -178 |
| Other Operating Activity | 1,334 | -1,049 | 3,977 | -1,934 | -4,576 |
| Operating Cash Flow | $-14,638 | $-10,288 | $-8,221 | $-8,868 | $-16,627 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -308 | -335 | -92 | -55 | -621 |
| Net Acquisitions | N/A | -2,000 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | -434 | 0 | 0 |
| Investing Cash Flow | $-308 | $-2,335 | $-525 | $-55 | $-621 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -151 | -8 | N/A | N/A | -2,187 |
| Common Stock Issued | 15,695 | 17,972 | 13,393 | N/A | 9 |
| Other Financing Activity | -94 | -1,318 | -70 | 0 | 32,545 |
| Financing Cash Flow | $15,450 | $16,646 | $13,323 | $N/A | $30,367 |
| Exchange Rate Effect | N/A | N/A | -197 | 134 | -211 |
| Beginning Cash Position | 14,732 | 10,709 | 6,329 | 15,117 | 2,210 |
| End Cash Position | 15,236 | 14,732 | 10,709 | 6,329 | 15,117 |
| Net Cash Flow | $504 | $4,023 | $4,380 | $-8,788 | $12,907 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,638 | -10,288 | -8,221 | -8,868 | -16,627 |
| Capital Expenditure | -308 | -335 | -92 | -55 | -621 |
| Free Cash Flow | -14,946 | -10,623 | -8,313 | -8,923 | -17,248 |